Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis.

Takanori NumataKatsutoshi NakayamaHirofumi UtsumiKenji KobayashiHaruhiko YanagisawaMitsuo HashimotoShunsuke MinagawaTakeo IshikawaHiromichi HaraJun ArayaKazuyoshi Kuwano

Published in: BMC pulmonary medicine (2019)

Both groups showed improved symptom scores and a decreased number of exacerbations. Mepolizumab substantially improved the clinical variables of patients with eosinophilic asthma complicated with ECRS.

Keyphrases

chronic rhinosinusitis
chronic obstructive pulmonary disease
cystic fibrosis
lung function
patient reported